Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 2
1994 2
1995 5
1996 1
1997 3
1998 4
1999 3
2000 2
2001 4
2002 2
2003 1
2004 2
2005 1
2006 3
2007 2
2008 8
2009 7
2010 5
2011 5
2012 5
2013 4
2014 3
2015 4
2016 2
2017 4
2019 2
2020 1
2021 3
2022 5
2023 7
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

93 results

Results by year

Filters applied: . Clear all
Page 1
Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures.
Pe M, Alanya A, Falk RS, Amdal CD, Bjordal K, Chang J, Cislo P, Coens C, Dirven L, Speck RM, Fitzgerald K, Galinsky J, Giesinger JM, Holzner B, Le Cessie S, O'Connor D, Oliver K, Pawar V, Quinten C, Schlichting M, Ren J, Roychoudhury S, Taphoorn MJB, Velikova G, Wintner LM, Griebsch I, Bottomley A; SISAQOL-IMI Consortium. Pe M, et al. Among authors: bjordal k. Lancet Oncol. 2023 Jun;24(6):e270-e283. doi: 10.1016/S1470-2045(23)00157-2. Lancet Oncol. 2023. PMID: 37269858 Free article. Review.
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial.
Trøseid M, Arribas JR, Assoumou L, Holten AR, Poissy J, Terzić V, Mazzaferri F, Baño JR, Eustace J, Hites M, Joannidis M, Paiva JA, Reuter J, Püntmann I, Patrick-Brown TDJH, Westerheim E, Nezvalova-Henriksen K, Beniguel L, Dahl TB, Bouscambert M, Halanova M, Péterfi Z, Tsiodras S, Rezek M, Briel M, Ünal S, Schlegel M, Ader F, Lacombe K, Amdal CD, Rodrigues S, Tonby K, Gaudet A, Heggelund L, Mootien J, Johannessen A, Møller JH, Pollan BD, Tveita AA, Kildal AB, Richard JC, Dalgard O, Simensen VC, Baldé A, de Gastines L, Del Álamo M, Aydin B, Lund-Johansen F, Trabaud MA, Diallo A, Halvorsen B, Røttingen JA, Tacconelli E, Yazdanpanah Y, Olsen IC, Costagliola D; EU SolidAct study group. Trøseid M, et al. Crit Care. 2023 Jan 10;27(1):9. doi: 10.1186/s13054-022-04205-8. Crit Care. 2023. PMID: 36627655 Free PMC article. Clinical Trial.
Long-term health-related quality of life in head and neck cancer survivors: A large multinational study.
Taylor KJ, Amdal CD, Bjordal K, Astrup GL, Herlofson BB, Duprez F, Gama RR, Jacinto A, Hammerlid E, Scricciolo M, Jansen F, Verdonck-de Leeuw IM, Fanetti G, Guntinas-Lichius O, Inhestern J, Dragan T, Fabian A, Boehm A, Wöhner U, Kiyota N, Krüger M, Bonomo P, Pinto M, Nuyts S, Silva JC, Stromberger C, Specenier P, Tramacere F, Bushnak A, Perotti P, Plath M, Paderno A, Stempler N, Kouri M, Grégoire V, Singer S; EORTC Quality of Life Group and the EORTC Head and Neck Group. Taylor KJ, et al. Among authors: bjordal k. Int J Cancer. 2024 May 15;154(10):1772-1785. doi: 10.1002/ijc.34861. Epub 2024 Feb 5. Int J Cancer. 2024. PMID: 38312044
Comparing the use of patient-reported outcomes in clinical studies in Europe in 2008 and 2018: a literature review.
Astrup GL, Rohde G, Rimehaug SA, Andersen MH, Bernklev T, Bjordal K, Falk RS, Jørgensen NMH, Stavem K, Tollisen A, Amdal CD; on behalf of PROMiNET. Astrup GL, et al. Among authors: bjordal k. Qual Life Res. 2022 Mar;31(3):659-669. doi: 10.1007/s11136-021-02946-7. Epub 2021 Aug 4. Qual Life Res. 2022. PMID: 34350566 Free PMC article. Review.
[Tumour-modifying therapy].
Aass N, Bjordal K, Tveit KM, Nordøy T. Aass N, et al. Among authors: bjordal k. Tidsskr Nor Laegeforen. 2006 Feb 23;126(5):628-32. Tidsskr Nor Laegeforen. 2006. PMID: 16505877 Free article. Review. Norwegian.
[Palliative cytostatic treatment].
Bjordal K, Aass N. Bjordal K, et al. Tidsskr Nor Laegeforen. 2004 Dec 16;124(24):3206-7. Tidsskr Nor Laegeforen. 2004. PMID: 15608767 Free article. Norwegian.
Health-related quality of life issues, including symptoms, in patients with active COVID-19 or post COVID-19; a systematic literature review.
Amdal CD, Pe M, Falk RS, Piccinin C, Bottomley A, Arraras JI, Darlington AS, Hofsø K, Holzner B, Jørgensen NMH, Kulis D, Rimehaug SA, Singer S, Taylor K, Wheelwright S, Bjordal K. Amdal CD, et al. Among authors: bjordal k. Qual Life Res. 2021 Dec;30(12):3367-3381. doi: 10.1007/s11136-021-02908-z. Epub 2021 Jun 19. Qual Life Res. 2021. PMID: 34146226 Free PMC article. Review.
93 results